Vida Ventures Advisors, LLC Kinnate Biopharma Inc. Transaction History

Vida Ventures Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 05, 2022	SELL	$9.86 - $15.76 $5.32 Million - $8.51 Million	-539,661 Reduced 19.64%	2,207,772 $26.4 Million
Q1 2021 May 11, 2021	BUY	$26.99 - $40.0 $9,689 - $14,360	359 Added 0.01%	2,747,433 $85.6 Million
Q4 2020 Feb 12, 2021	BUY	$36.35 - $45.25 $99.9 Million - $124 Million	2,747,074 New	2,747,074 $109 Million

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Vida Ventures Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Vida Ventures Advisors, LLC with notifications on news.